论文部分内容阅读
目的观察脑心通联合氯吡格雷治疗短暂性脑缺血发作临床疗效。方法 93例短暂性脑缺血发作患者,随机分为治疗组(47例)和对照组(46例)。治疗组采用口服脑心通联合氯吡格雷;对照组采用拜阿司匹林联合氯吡格雷,比较治疗期内两组临床结局情况。结果治疗组和对照组治疗有效率分别为95.7%(45/47)和95.7%(44/46),比较差异无统计学意义(P>0.05)。结论脑心通联合氯吡格雷治疗短暂性脑缺血发作同拜阿司匹林联合氯吡格雷治疗短暂性脑缺血发作疗效相同,值得临床推广应用。
Objective To observe the clinical effect of Naoxintong combined with clopidogrel in the treatment of transient ischemic attack. Methods A total of 93 patients with transient ischemic attack were randomly divided into treatment group (n = 47) and control group (n = 46). The treatment group was treated with oral Naoxintong combined with clopidogrel; the control group was treated with aspirin combined with clopidogrel to compare the clinical outcome of the two groups during the treatment period. Results The effective rates of the treatment group and the control group were 95.7% (45/47) and 95.7% (44/46) respectively, with no significant difference (P> 0.05). Conclusion Naoxintong combined with clopidogrel in the treatment of transient ischemic attacks with aspirin plus clopidogrel in the treatment of transient ischemic attack the same effect, worthy of clinical application.